GABA
Also sold as: Gamma-aminobutyric acid · GABA · Fermented GABA
An inhibitory neurotransmitter sold as an oral relaxation and sleep supplement. Oral dosing does not establish that meaningful amounts enter the brain.
Anxiety Sleep Focus
Community
Not enough ratings yet: 0 of 10
Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.
Research
- Sleep: A trial in sedentary overweight women undergoing exercise reported better sleep efficiency; it does not isolate a general sleep benefit from GABA alone.
- Focus: No established cognitive-performance benefit from isolated oral GABA. A null trial of GABA-producing bacteria is indirect evidence, not a negative trial of pure GABA.
- Anxiety: Small acute stress-challenge studies found EEG and self-reported relaxation signals; sustained treatment of an anxiety disorder is unproven.
REALITY CHECK // Small studies support possible acute relaxation, with uncertain clinical importance. Oral GABA is not proven to replenish brain GABA, and food-matrix or exercise studies cannot establish a pure-GABA sleep or blood-pressure protocol. It is a different substance from phenibut.
Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.
Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.
Check your bottle
Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.
Enter the amount from your label to see the result.
How it was studied
UPPER LIMIT // No EFSA or NIH tolerable upper intake level is established in the dossier. The 3,000 mg experimental dose is not a safety ceiling; long-term safety is inadequately studied.
Summary
GABA has small, short-term relaxation signals rather than a robust clinical anti-anxiety effect. Blood-pressure findings involve foods, the prediabetes trial was largely null, and an acute growth-hormone spike is not muscle growth.
Mechanism
Endogenous GABA is an inhibitory neurotransmitter. Whether supplemented GABA crosses the blood-brain barrier in meaningful amounts remains disputed; peripheral autonomic or gut-brain pathways could contribute to observed effects.
Typical studied dose
Human relaxation studies used 100 mg acutely, with EEG changes around 60 minutes in one small study. The dossier describes approximately 100-800 mg in human supplement studies and a separate 3,000 mg acute growth-hormone experiment; these are different outcomes, not interchangeable targets.
Upper limit
No EFSA or NIH tolerable upper intake level is established in the dossier. The 3,000 mg experimental dose is not a safety ceiling; long-term safety is inadequately studied.
Popular stacks with GABA
Not enough stack data yet. A combination with GABA appears here once 5 people rate the same set.
Forms and label traps
| Form on label | Active content | Studied range / day | Absorption & GI tolerance | Verdict |
|---|---|---|---|---|
| Synthetic GABA / free amino acid Best for: Comparing the labeled mass of pure GABA with the dossier supplement range. |
Extract weight · ~100% marker | 100–800 mg | Absorbed from the gut, but clinically meaningful brain entry is uncertain. Usually tolerated at 100-800 mg; larger acute amounts may cause flushing, tingling or breathlessness. |
Studied standard [REFERENCE // STUDIED_FORM] 100% means pure GABA mass, not an elemental fraction or proof of brain delivery. The separate 3 g GH experiment is not the relaxation target. |
| Fermented GABA / PharmaGABA Best for: Readers checking whether a fermentation premium changes the evidence. |
Extract weight · ~100% marker | 100–800 mg | Chemically the same GABA molecule; convincing superiority over synthetic GABA is not established. Similar precautions to synthetic GABA. |
Caution [CAUTION // CHECK_BASIS] The range is general oral-GABA context, not a verified brand-specific efficacy interval. There is no head-to-head superiority evidence in this dossier. |
Common label traps
- TRAP_01 // A natural benzodiazepine
Clinically important brain entry is uncertain. Small EEG and self-report studies do not establish equivalence to prescription anti-anxiety drugs. - TRAP_02 // Fermented means more effective
The molecule is chemically identical; a meaningful clinical advantage is not established. - TRAP_03 // Growth hormone means bigger muscles
The 3 g study measured an acute GH response, not chronic muscle size, strength or body composition. - TRAP_04 // GABA regulates blood sugar
The double-blind prediabetes RCT did not show meaningful improvement in its main glucose-control outcomes.
Other outcomes studied
Outside the five leaderboard goals. Same evidence levels as above.
- BLOOD PRESSURE / FOOD MATRIX Limited · benefit
RCTs in mild or borderline hypertension found reductions with GABA-containing fermented milk or Chlorella. Effects cannot be fully assigned to isolated GABA.
PMID 12627188 PMID 19811362 - PREDIABETES / GLUCOSE CONTROL Limited · no benefit
The double-blind RCT was largely null for primary glucose-control measures; pancreatic mechanisms do not establish a supplement benefit.
PMID 37495019 - ACUTE GROWTH HORMONE Limited · benefit
A 3 g acute experiment in young men increased circulating GH isoforms at rest and after resistance exercise. No chronic anabolic effect was demonstrated.
PMID 18091016 PMID 23075553 - COGNITION / PROBIOTIC STUDY Limited · no benefit
GABA-producing lactobacilli altered cognitive reactivity to negative mood without improving cognitive performance. This intervention is not a pure oral-GABA supplement.
PMID 39163908
Reader questions
Does swallowed GABA reach the brain?
Meaningful passage across the blood-brain barrier remains disputed. Peripheral or gut-brain effects are plausible; feeling relaxed does not identify the route.
What dose and timing were studied?
Acute stress experiments used 100 mg, with one EEG assessment around 60 minutes. The broader dossier range is 100-800 mg; the 3 g hormone experiment is a separate endpoint. A general bedtime prescription cannot be derived from these mixed studies.
Does long-term GABA cause tolerance or dependence?
Long-term controlled safety data are missing. Receptor down-regulation is a theoretical concern, not an established consequence of oral GABA. Do not confuse GABA with phenibut, which has a different risk profile.
Why do some people report worse sleep?
Responses vary in user reports, including insomnia or no effect, but those reports do not prove a mechanism or frequency. Stop and review persistent paradoxical symptoms instead of escalating the dose.
Can it be combined with medicines or alcohol?
A clinician should review blood-pressure medicines, anticonvulsants and sedatives. Alcohol or multiple calming agents can compound drowsiness even though direct GABA interaction studies are limited.
Stack interactions
- Caution Alcohol, benzodiazepines and sleep medicines [CAUTION // CLINICAL_REVIEW]
Possible additive sedation is a precaution based on overlapping effects, not a quantified interaction trial. Avoid unsupervised combinations and driving when drowsy. - Caution Blood-pressure medicines [CAUTION // CLINICAL_REVIEW]
GABA-rich fermented milk and Chlorella lowered blood pressure in selected populations. The food matrix confounds attribution, but excessive lowering with treatment remains a reasonable precaution.
PMID 12627188 PMID 19811362 - Caution Anticonvulsants and other GABAergic agents [CAUTION // CLINICAL_REVIEW]
Potential mechanistic overlap warrants specialist review; this dossier does not establish a specific pharmacokinetic interaction. - Caution Calming supplements [CAUTION // CLINICAL_REVIEW]
Theanine, valerian, magnesium and melatonin may add drowsiness. The combined stack has not been validated by the single-ingredient studies.
Red flags: interactions and who should avoid it
Interactions
Potential additive drowsiness with alcohol, sedatives, sleep medicines and calming supplements is precautionary because direct interaction data are weak. Blood-pressure medicines may compound hypotension. Anticonvulsants or glucose-lowering medicines warrant clinical review; the prediabetes RCT does not establish glucose-lowering efficacy.
Avoid or ask a doctor first if
Avoid unsupervised supplementation in pregnancy, breastfeeding or children because safety data are absent. Review sedative, anticonvulsant and blood-pressure medicines first. Drowsiness can impair driving. High acute doses have caused tingling, flushing and breathlessness; new or severe breathing symptoms require medical assessment rather than assuming a harmless reaction.
Sources (PubMed, 10)
- Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans.
PMID 16971751 · 2006 · randomized controlled trialSmall acute human study: relaxation self-report and EEG changes after 100 mg, rather than a durable anxiety-disorder outcome.
- Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks.
PMID 22203366 · 2012 · randomized controlled trialMental-task stress trial: EEG and mood signals with oral GABA; small, short-term endpoints.
- GABA Supplementation, Increased Heart-Rate Variability, Emotional Response, Sleep Efficiency and Reduced Depression in Sedentary Overweight Women Undergoing Physical Exercise: Placebo-Controlled, Randomized Clinical Trial.
PMID 38321713 · 2024 · randomized controlled trialSleep-efficiency and autonomic/emotional outcomes in sedentary overweight women undergoing an exercise program; limited attribution to GABA alone.
- Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives.
PMID 12627188 · 2003 · randomized controlled trialFermented milk containing GABA lowered blood pressure in mild hypertension; the matrix prevents pure-ingredient attribution.
- Anti-hypertensive effect of gamma-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study.
PMID 19811362 · 2009 · randomized controlled trialGABA-rich Chlorella study in high-normal or borderline hypertension; food-matrix evidence.
- Effects of γ-aminobutyric acid supplementation on glucose control in adults with prediabetes: A double-blind, randomized, placebo-controlled trial.
PMID 37495019 · 2023 · randomized controlled trialPrediabetes RCT: largely null primary glucose-control findings in the dossier.
- Growth hormone isoform responses to GABA ingestion at rest and after exercise.
PMID 18091016 · 2008 · randomized controlled trialAcute 3 g GABA increased GH isoform responses; no chronic hypertrophy endpoint.
- GABA supplementation and growth hormone response.
PMID 23075553 · 2012 · narrative reviewReview of the acute GH-response literature; not evidence of muscle gain.
- Gaba-producing lactobacilli boost cognitive reactivity to negative mood without improving cognitive performance: A human Double-Blind Placebo-Controlled Cross-Over study.
PMID 39163908 · 2024 · randomized controlled trialGABA-producing lactobacilli did not improve cognitive performance; indirect intervention evidence only.
- Neurotransmitters as food supplements: the effects of GABA on brain and behavior.
PMID 26500584 · 2015 · narrative reviewReview discussing uncertain brain entry and alternative pathways for supplemental GABA.
Community comments
No approved comments yet. Comments are held for moderation.